Q&A: ‘I’m going overseas tomorrow . . . can you witness...

While pharmacists are now (very) familiar with rapid antigen tests (RATs) for COVID-19 testing, the practice of observed RATs for the purpose of international...

PSA’s projects make a bigger impact than ever before

The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.

Treating hypertension – a new approach

Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians. Research has indicated that a new pharmacological...

Q&A: Shadow Federal Health Minister Catherine King

As a supporter of pharmacists, Catherine King MP is a firm believer in having a ‘broader’ role for pharmacists in Australia’s health system. During her...

Re-thinking opioids

Pharmacists can minimise opioid harm by helping patients step down. While opioids play an important role in the management of acute pain, their widespread use...

Pharmacist interpreting service gets major expansion

Pharmacists have been given a powerful new tool for giving advice to Australia’s diverse communities, after the Department of Social Services substantially expanded access...